|82 Devonshire St , Boston, MA 02109|
|Fund Manager||Team Managed|
The fund seeks a high level of current income.The fund may also seek capital appreciation.nvesting primarily in debt securities,including lower-quality debt securities (those of less than investment-grade quality, also referred to as high yield debt securities or junk bonds).Allocating the fund's assets among four general investment categories: high yield securities,U.S.Government and investment-grade securities,emerging market securities,and foreign developed market securities.Potentially investing in equity securities.Using a neutral mix of approximately 45% high yield,25% U.S.Government and investment-grade,15% emerging markets,and 15% foreign developed markets.Analyzing a security's structural features and current pricing,its issuer's potential for success,and the credit,currency,and economic risks of the security and its issuer to select investments.Hedging the fund's foreign currency exposures utilizing forward foreign currency exchange contracts.Engaging in transactions that have a leveraging effect on the fund, including investments in derivatives - such as swaps(interest rate,total return,and credit default),options, and futures contracts - and forward-settling securities,to adjust thefund's risk exposure.Investing in Fidelity's central funds (specialized investment vehicles used by FidelityÂ® funds to invest in particular security types or investment disciplines).
|Asset Type||% Of Allocation|
|Total Net Assets||797.05 M|
|Criteria||3 Years||5 Years||10 Years|
|Minimum Initial IRA||$0|
|Timeframe||Average Annual Current Performance Monthly As Of 09/30/2021||Average Annual Current Performance Quarterly As Of 09/30/2021||Avg Annual Current Performance Monthly As Of 09/30/2021||Avg Annual Current Performance Quarterly As Of 09/30/2021|
|Life Of Fund||
Master The Market with the Help of Our Financial Experts
Stocks moving in premarket trading include Procter & Gamble. Ulta, Netflix, Johnson & Johnson and Teladoc.
Atea Pharmaceuticals could shed more than $2 billion in value Tuesday after the drugmaker said a mid-stage trial of its developing COVID treatment failed to meet expectations.
Cloud-software growth stocks have been a bright spot in an uncertain market. Investors might look closely at Cloudflare and Digital Ocean.
Philip Morris posts a third-quarter earnings beat as sales of its smokeless non-tobacco products continue strong, though cautions on supply chain impact.
Travelers Companies posts third-quarter earnings that exceed analysts’ forecasts as a drop in what it calls ‘catastrophic losses’ offsets record net written premiums.
Solid third quarters continue to power stocks higher Tuesday, even as growth and inflation signals remain stubbornly persistent as oil prices top $85 a barrel in overnight trading.
Procter & Gamble held its 2022 forecasts in place, seeing sales growth of between 2% and 4%, following stronger-than-expected first quarter earnings.
Johnson & Johnson said it sees 2021 vaccine sales of $2.5 billion, with overall revenues rising to between $94.1 billion to $94.6 billion, following its Q3 earnings beat.
Stocks edge higher ahead of earnings; SEC says GameStop surge powered by believers; FDA set to approve "mix & match' COVID boosters; DraftKings faces Entain bid deadline and Rent the Runway seeks $1.3 billion valuation in Nasdaq IPO.